BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boyer O, Butler-Browne G, Chinoy H, Cossu G, Galli F, Lilleker JB, Magli A, Mouly V, Perlingeiro RCR, Previtali SC, Sampaolesi M, Smeets H, Schoewel-Wolf V, Spuler S, Torrente Y, Van Tienen F; Study Group. Myogenic Cell Transplantation in Genetic and Acquired Diseases of Skeletal Muscle. Front Genet 2021;12:702547. [PMID: 34408774 DOI: 10.3389/fgene.2021.702547] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Deprez A, Orfi Z, Rieger L, Dumont NA. Impaired muscle stem cell function and abnormal myogenesis in acquired myopathies. Biosci Rep 2023;43. [PMID: 36538023 DOI: 10.1042/BSR20220284] [Reference Citation Analysis]
2 Brunet A, Goodell MA, Rando TA. Ageing and rejuvenation of tissue stem cells and their niches. Nat Rev Mol Cell Biol 2023;24:45-62. [PMID: 35859206 DOI: 10.1038/s41580-022-00510-w] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
3 Deng P, Qiu S, Liao F, Jiang Y, Zheng C, Zhu Q. Contusion concomitant with ischemia injury aggravates skeletal muscle necrosis and hinders muscle functional recovery. Exp Biol Med (Maywood) 2022;247:1577-90. [PMID: 35775612 DOI: 10.1177/15353702221102376] [Reference Citation Analysis]
4 Kim H, Perlingeiro RCR. Generation of human myogenic progenitors from pluripotent stem cells for in vivo regeneration. Cell Mol Life Sci 2022;79:406. [PMID: 35802202 DOI: 10.1007/s00018-022-04434-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Tasca F, Brescia M, Wang Q, Liu J, Janssen JM, Szuhai K, Gonçalves MAFV. Large-scale genome editing based on high-capacity adenovectors and CRISPR-Cas9 nucleases rescues full-length dystrophin synthesis in DMD muscle cells. Nucleic Acids Res 2022:gkac567. [PMID: 35776127 DOI: 10.1093/nar/gkac567] [Reference Citation Analysis]
6 Stadelmann C, Di Francescantonio S, Marg A, Müthel S, Spuler S, Escobar H. mRNA-mediated delivery of gene editing tools to human primary muscle stem cells. Mol Ther Nucleic Acids 2022;28:47-57. [PMID: 35356683 DOI: 10.1016/j.omtn.2022.02.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
7 Metzler E, Escobar H, Sunaga-franze DY, Sauer S, Diecke S, Spuler S. Generation of hiPSC-Derived Skeletal Muscle Cells: Exploiting the Potential of Skeletal Muscle-Derived hiPSCs. Biomedicines 2022;10:1204. [DOI: 10.3390/biomedicines10051204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Yedigaryan L, Sampaolesi M. Therapeutic Implications of miRNAs for Muscle-Wasting Conditions. Cells 2021;10:3035. [PMID: 34831256 DOI: 10.3390/cells10113035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
9 Tripodi L, Villa C, Molinaro D, Torrente Y, Farini A. The Immune System in Duchenne Muscular Dystrophy Pathogenesis. Biomedicines 2021;9:1447. [PMID: 34680564 DOI: 10.3390/biomedicines9101447] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]